Back to search
FDAFDA · Food and drugs·Recall number Z-1644-2018

RESTORIS MCK TIBIAL BASEPLATE-RM/LL used in unicompartmental knee arthroplasty and knee replacements.

Published May 16, 2018 · Recall initiated: December 1, 2017

Summary

FDA records medical device Class II recall Z-1644-2018, published May 16, 2018 and initiated December 1, 2017. Recalling firm: Mako Surgical Corporation; Status: Terminated; Reported quantity: 126; Lot: Size 2 Item # 180612 Lot # 26080317-01 and Size 7 Item # 180617 Lot # 26150217-01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect product and/or label. Sizing is labeled incorrectly.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mako Surgical Corporation
Distributor
AL, AR, AZ, CA, CO, FL, GA, ID, IL, IN, KS, LA, MA, MD, MI, MN, NC, NE, NH, NJ, NY, OK, OR, PA, RI, SC, TX, UT, VA, WA, WY, and Hawaii Australia, Italy, Netherlands, Singapore, South Korea, United Kingdom, and Vietnam
Lot
Size 2 Item # 180612 Lot # 26080317-01 and Size 7 Item # 180617 Lot # 26150217-01.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was RESTORIS MCK TIBIAL BASEPLATE-RM/LL used in unicompartmental knee arthroplasty and knee replacements. recalled?

Yes. FDA published recall Z-1644-2018 on May 16, 2018. Reported hazard: Incorrect product and/or label. Sizing is labeled incorrectly.

What should I do if I have this product?

Voluntary: Firm initiated · Letter